Optimization of multi‐stage dynamic treatment regimes utilizing accumulated data

Xuelin Huang(The University of Texas MD Anderson Cancer Center), Peter F. Thall(The University of Texas MD Anderson Cancer Center), Sangbum Choi(The University of Texas MD Anderson Cancer Center), Lu Wang(University of Michigan)
Statistics in Medicine
June 21, 2015
10.1002/sim.6558
Cited by 46

Related Papers

An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis.
|PubMed|2013|1.6k
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
|Blood|2006|691
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
|Blood|2001|570
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
|Blood|2001|516
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
|Nature Medicine|2024|452